Pyxis Oncology, Inc. - stock earnings
PYXS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -23.0 million USD | ? USD |
| 2023Q2 | -15.9 million USD | ? USD |
| 2023Q1 | -17.5 million USD | ? USD |
| 2022Q4 | 22.9 million USD | ? USD |
| 2022Q3 | -27.0 million USD | ? USD |
| 2022Q2 | -25.4 million USD | ? USD |
| 2022Q1 | -31.4 million USD | ? USD |
| 2021Q4 | -16.8 million USD | ? USD |
| 2021Q3 | -14.2 million USD | ? USD |
| 2021Q2 | -8.1 million USD | ? USD |
| 2021Q1 | -36.8 million USD | ? USD |
| 2020Q4 | -4.6 million USD | ? USD |
| 2020Q3 | -3.2 million USD | ? USD |
PYXS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -73.8 million USD | ? USD |
| 2022 | -118.0 million USD | ? USD |
| 2021 | -81.5 million USD | ? USD |
| 2020 | -12.8 million USD | ? USD |
| 2019 | -2.7 million USD | ? USD |
PYXS
Price: $4.34
52 week price:
Earnings Per Share: -1.85 USD
P/E Ratio: -2.10
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 10300
Market Capitalization: 272.6 million